KY1022
/ Yonsei University
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 23, 2022
API-2-Induced Cell Migration Is Overcome by Small Molecular Approaches Inhibiting β-Catenin.
(PubMed, Curr Issues Mol Biol)
- "In this study, we discover that the combinatorial treatment of an AKT inhibitor and KY1022, a β-catenin destabilizer, effectively overcomes the current limitations of API-2, an AKT inhibitor, by reducing nuclear β-catenin. Taken together, we demonstrate that the simultaneous suppression of Wnt/β-catenin with the AKT signaling pathways is an ideal strategy for suppressing the AKT-inhibitor-mediated metastasis and for maximizing the therapeutic effects of AKT inhibitors."
Journal • Colorectal Cancer • Gastrointestinal Cancer • Oncology • Solid Tumor • APC • CTNNB1
1 to 1
Of
1
Go to page
1